LexaGene’s Technology Successfully Detects Antibiotic Resistance Factors

LexaGene Holdings Inc, a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced today that its LX technology can detect the presence of antibiotic resistance factors from pathogens that cause urinary tract infections (UTIs) in dogs.

Article: CRWE World